A peanut patch treatment (Viaskin Peanut Patch; [VP250]) continues to help toddlers safely build tolerance to peanuts over 3 years.

TODDLERS could safely build their tolerance to peanut allergies with a new skin patch treatment, say scientists. The findings ...

The study found that a peanut patch treatment—called epicutaneous immunotherapy, or EPIT—continued to help toddlers safely ...

According to the CDC, an estimated 1 in 13 children have food allergies. And at least 2 in 5 children, or 40 percent, have ...

More than 70% of children treated with the Viaskin Peanut Patch could tolerate at least three to four peanut kernels without ...

Blockbuster research has upended assumptions about the allergy. Experts shared what parents should know about introducing ...

New research shows that early peanut introduction at 4 to 11 months reduces peanut allergies by 43% in children under 3, challenging old guidelines that waited until age 3.

A study's findings add to growing evidence that early intervention in young children could help change the course of peanut ...

Now, some may argue, “Oh, I have a peanut allergy, and it’s real.” Firstly, no, you don’t. Secondly, what you think you have, ...

A new study published in the journal Pediatrics shows peanut allergies are becoming less common in the United States.

The drug, Palforzia, also comes with "potentially serious side effects." A drug designed to minimize the frequency and severity of a child's allergic reaction to peanuts was approved Friday by the U.S ...